UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
2017, ISBN 012804831X, 253
eBook
British journal of pharmacology, ISSN 0007-1188, 06/2012, Volume 166, Issue 3, pp. 877 - 894
type 1 diabetes | animal models | type 2 diabetes | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Diabetes. Impaired glucose tolerance | Pharmacology. Drug treatments | Biological and medical sciences | Endocrinopathies | Etiopathogenesis. Screening. Investigations. Target tissue resistance | Medical sciences | Endocrine pancreas. Apud cells (diseases) | Obesity - complications | Diabetes Mellitus, Type 2 - genetics | Diabetes Mellitus, Experimental - genetics | Insulin Resistance | Diabetes Mellitus, Type 1 - genetics | Streptozocin - administration & dosage | Obesity - blood | Streptozocin - pharmacology | Insulin-Secreting Cells - immunology | Diabetes Mellitus, Experimental - immunology | Animals | Diabetes Mellitus, Experimental - etiology | Diabetes Mellitus, Type 1 - etiology | Insulin-Secreting Cells - virology | Diabetes Mellitus, Type 2 - immunology | Diabetes Mellitus, Type 1 - chemically induced | Dietary Fats - administration & dosage | Diabetes Mellitus, Type 2 - etiology | Diabetes Mellitus, Experimental - chemically induced | Diabetes Mellitus, Type 1 - immunology | Diabetes Mellitus, Type 2 - chemically induced | Insulin-Secreting Cells - pathology | Blood Glucose - metabolism | Index Medicus | Reviews
Journal Article
Nature medicine, ISSN 1078-8956, 05/2019, Volume 25, Issue 5, pp. 805 - 813
Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Cell Biology | Research & Experimental Medicine | Prognosis | Prospective Studies | Diabetic Nephropathies - etiology | Diabetes Mellitus, Type 2 - genetics | Humans | Middle Aged | Male | Diabetes Mellitus, Type 1 - complications | Diabetic Nephropathies - blood | Blood Proteins - metabolism | Blood Proteins - genetics | Receptors, Tumor Necrosis Factor - blood | Adult | Female | Diabetes Mellitus, Type 2 - complications | Receptors, Tumor Necrosis Factor - genetics | Risk Factors | Inflammation Mediators - blood | Diabetes Mellitus, Type 1 - genetics | Diabetic Nephropathies - genetics | Biomarkers - blood | Disease Progression | Kidney Failure, Chronic - genetics | Diabetes Mellitus, Type 2 - blood | Kidney Failure, Chronic - blood | Diabetes Mellitus, Type 1 - blood | Proteomics | Aged | Cohort Studies | Kidney Failure, Chronic - etiology | Complications and side effects | Chronic kidney failure | Tumor necrosis factor | Cytokine receptors | Development and progression | Diabetes | Health aspects | Risk factors | End-stage renal disease | Kidneys | Therapeutic applications | Medical treatment | Diabetes mellitus | Health risks | Risk | Diabetes mellitus (insulin dependent) | Inflammation | Proteins | Developmental stages | Biomarkers | Kidney diseases | Diabetes mellitus (non-insulin dependent) | Index Medicus
Journal Article
Journal of diabetes research, ISSN 2314-6745, 8/2016, Volume 2016, pp. 9051426 - 12
Animals | Diabetes Mellitus, Type 2 - physiopathology | Diabetes Mellitus, Type 1 - physiopathology | Diabetes Mellitus, Type 1 - metabolism | Rats | Mice | Diabetes Mellitus, Type 2 - metabolism | Blood Glucose - metabolism | Diabetes Mellitus, Experimental - metabolism | Diabetes Mellitus, Experimental - physiopathology | Disease Models, Animal | Obesity | Insulin resistance | Mutation | Rodents | Index Medicus | Review
Journal Article
Journal of ethnopharmacology, ISSN 0378-8741, 11/2016, Volume 192, pp. 382 - 389
PI3K/Akt signaling pathway | Liuwei Dihuang decoction | Type 2 diabetes mellitus | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Chemistry, Medicinal | Integrative & Complementary Medicine | Plant Sciences | Science & Technology | Diabetes Mellitus, Experimental - drug therapy | Liver - pathology | Phosphorylation | Liver - enzymology | Diabetes Mellitus, Experimental - enzymology | Streptozocin | Drugs, Chinese Herbal - pharmacology | Male | Insulin Receptor Substrate Proteins - metabolism | Insulin - blood | RNA, Messenger - metabolism | Proto-Oncogene Proteins c-akt - genetics | Diabetes Mellitus, Experimental - blood | Liver - drug effects | Time Factors | Diabetes Mellitus, Experimental - chemically induced | Insulin Receptor Substrate Proteins - genetics | Proto-Oncogene Proteins c-akt - metabolism | Phosphatidylinositol 3-Kinase - metabolism | Pancreas - enzymology | RNA, Messenger - genetics | Diabetes Mellitus, Type 2 - enzymology | Insulin Resistance | Pancreas - drug effects | Pancreas - pathology | Biomarkers - blood | Rats, Sprague-Dawley | Hypoglycemic Agents - pharmacology | Blood Glucose - drug effects | Gene Expression Regulation, Enzymologic | Diabetes Mellitus, Type 2 - blood | Animals | Phosphatidylinositol 3-Kinase - genetics | Signal Transduction - drug effects | Diabetes Mellitus, Type 2 - chemically induced | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Type 2 diabetes | Insulin resistance | Medicine, Chinese | Liver | Physiological aspects | Blood sugar | Index Medicus
Journal Article
Kidney international, ISSN 0085-2538, 01/2018, Volume 93, Issue 1, pp. 95 - 109
cytokines | fibrosis | inflammation | mesangial cells | diabetic nephropathy | Life Sciences & Biomedicine | Urology & Nephrology | Science & Technology | Diabetes Mellitus, Experimental - drug therapy | Kidney - pathology | Rats, Wistar | Diabetic Nephropathies - etiology | Humans | JNK Mitogen-Activated Protein Kinases - metabolism | Male | NF-kappa B - metabolism | Diabetes Mellitus, Type 1 - complications | Diabetic Nephropathies - blood | Diabetes Mellitus, Experimental - blood | Kidney - metabolism | Inflammation Mediators - metabolism | Diabetes Mellitus, Experimental - complications | Diabetic Nephropathies - prevention & control | Diabetes Mellitus, Type 2 - complications | Cell Line | Diabetic Nephropathies - pathology | Kidney - drug effects | Cytokines - metabolism | Anti-Inflammatory Agents - pharmacology | Mice, Inbred C57BL | Recombinant Proteins - pharmacology | Diabetes Mellitus, Type 1 - drug therapy | Blood Glucose - drug effects | Fibroblast Growth Factor 1 - blood | Diabetes Mellitus, Type 2 - blood | Macrophages - metabolism | Animals | Signal Transduction - drug effects | Diabetes Mellitus, Type 1 - blood | Fibroblast Growth Factor 1 - pharmacology | Macrophages - drug effects | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | Index Medicus
Journal Article
European journal of pharmacology, ISSN 0014-2999, 04/2014, Volume 728, Issue 1, pp. 135 - 140
Type 2 diabetes | Atorvastatin | Insulin resistance | Hypertriglyceridemia | Impaired glucose tolerance | Glucose area under the curve | Life Sciences & Biomedicine | Pharmacology & Pharmacy | Science & Technology | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Glucose Tolerance Test | Blood Glucose - analysis | Rats, Wistar | Cholesterol - blood | Heptanoic Acids - therapeutic use | Diabetes Mellitus, Type 2 - prevention & control | Insulin Resistance | Body Weight - drug effects | Rats | Male | Diabetes Mellitus, Type 2 - metabolism | Insulin - blood | Atorvastatin Calcium | Animals | Diabetes Mellitus, Experimental - prevention & control | Pyrroles - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Lipid Metabolism - drug effects | Triglycerides - blood | Heptanoic Acids - administration & dosage | Diabetes Mellitus, Experimental - metabolism | Pyrroles - therapeutic use | Prevention | Glucose metabolism | Streptozocin | Analysis | Body weight | Physiological aspects | Glucose | Dextrose | Antilipemic agents | Index Medicus
Journal Article